High Throughput Screening (HTS) - Global Strategic Business Report

Report
273 Pages
May 2024
Region: Global
Global Industry Analysts, Inc
ID: 1882081

The global market for High Throughput Screening (HTS) is estimated at US$40.4 Billion in 2023 and is projected to reach US$45.3 Billion by 2030, growing at a CAGR of 1.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the HTS Consumables / Reagents segment, which is expected to reach US$16.9 Billion by 2030 with a CAGR of a 3.7%. The HTS Instruments segment is also set to grow at -5.1% CAGR over the next 7 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $10.6 Billion in 2023, and China, forecasted to grow at an impressive 5.9% CAGR to reach $11.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global High Throughput Screening (HTS) Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global High Throughput Screening (HTS) Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global High Throughput Screening (HTS) Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Aurora Biomed Inc., Axxam SpA, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 41 Featured):

Agilent Technologies, Inc.
Aurora Biomed Inc.
Axxam SpA
BD Biosciences
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
BioTek Instruments Inc.
BMG LABTECH GmbH
Charles River Laboratories International Inc.
Corning Inc.
Danaher Corporation
Evotec AG
F. Hoffmann-La Roche Ltd.
Genedata AG
IntelliCyt® Corporation
Luminex Corporation
Molecular Devices Inc.
Pall ForteBio LLC
PerkinElmer Inc.
Sigma-Aldrich Corp.
Tecan Group Ltd.
Thermo Fischer Scientific Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
High Throughput Screening (HTS): A Prelude
Recent Market Activity
HTS: The Mainstream Technology for Drug Discovery Programs
Unparalleled Advantages in Compound Screening Drives Wider Adoption
Key Benefits of HTS - An Overview
Soaring R&D Spending Creates Conducive Environment for HTS
Shift towards High Throughput Research Builds Momentum for HTS
Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
STable Economic Outlook to Keep Market Sentiment Intact in the Near Term
Developed Regions: Key Revenue Contributors
HTS Adoption Continues to Expand in Developing Regions
Key Factors Driving Demand for HTS in the Developing Regions
Competitive Scenario
Leading Players in the World HTS Market
M&A Activity
High Throughput Screening (HTS) - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update

2. FOCUS ON SELECT PLAYERS

Agilent Technologies, Inc. (USA)
Aurora Biomed, Inc. (Canada)
Axxam SpA (Italy)
BD Biosciences (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
Molecular Devices Inc. (USA)
Pall ForteBio LLC (USA)
Bio-Rad Laboratories, Inc. (USA)
BioTek Instruments Inc. (USA)
BMG LABTECH GmbH (Germany)
Charles River Laboratories International, Inc. (USA)
Corning Inc. (USA)
DiscoveRx Corporation (USA)
Evotec AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genedata AG (Switzerland)
IntelliCyt® Corporation (USA)
Luminex Corporation (USA)
PerkinElmer, Inc. (USA)
Sigma-Aldrich Corp. (USA)
Tecan Group Ltd. (Switzerland)
Thermo Fisher Scientific Inc. (USA)

3. MARKET TRENDS & DRIVERS

Cell-based Assay: The Widely Used HTS Technology
Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
HTS Aims to Expand Use Case in Biochemical Applications
Label-Free HTS Demonstrates Fastest Growth
Lab-on-a-Chip HTS Seeks to Proliferate the Market
Bioinformatics HTS Enhanced with Computational Algorithms
Positive Prognosis across End-Use Markets to Underpin Revenue Growth
Pharmaceutical Industry Leads the Way
HTS Deployments Soar in Academia
Progressive Advancements in HTS Instruments Accelerate Market Growth
Microplate Handling Systems: An Important HTS Instrument Type
Liquid Handling Devices: A Necessity in HTS Processes
Microscopic Systems Facilitate Seamless Quantitative Analysis
Advanced Software Platforms Augment HTS Proficiency
Services: An Important Revenue Generating Segment
Expansion in Compound Libraries Widens Functional Scope of HTS
Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
Laboratory Automation & Miniaturization Spell Opportunities for HTS
Miniaturization of Compound Screening Processes Drives Demand for HTS
HTS Miniaturization - Technology Developments
HTS Robotics Support Miniaturization
IVC - A Miniaturized, Powerful HTS Technology
HTS Assumes Critical Importance in Target Identification & Validation
HTS Gathers Steam in Primary Screening Applications
HTS Perceives Bright Future in Stem Cell Research
HTS in Kinase Inhibitors Identification
HTS in Alzheimer's Disease Drug Discovery
HTS for Less Simplified PCR Systems
HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
Open Access Platforms Widen HTS Audience Base
Need for Stringent QA System to Keep Failures at Bay
High Throughput Screening (HTS) Vs. High Content Screening (HCS)
Rise in Adoption of HCS Technology in HTS Laboratories

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for High Throughput Screening (HTS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Consumables/Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Consumables/Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Consumables/Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Cell-based Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Cell-based Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for Cell-based Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for Label-Free Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for Label-Free Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 18: World 16-Year Perspective for Label-Free Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 21: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 23: World Historic Review for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 24: World 16-Year Perspective for Target Identification & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 26: World Historic Review for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 27: World 16-Year Perspective for Primary & Secondary Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 28: World Recent Past, Current & Future Analysis for Toxicology Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 29: World Historic Review for Toxicology Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 30: World 16-Year Perspective for Toxicology Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 34: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 35: World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 36: World 16-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 37: World Recent Past, Current & Future Analysis for Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 38: World Historic Review for Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 39: World 16-Year Perspective for Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 40: World Recent Past, Current & Future Analysis for Contract Research Organizations (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 41: World Historic Review for Contract Research Organizations (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 42: World 16-Year Perspective for Contract Research Organizations (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 43: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 44: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 45: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 46: World Recent Past, Current & Future Analysis for Consumables / Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
Table 47: World Historic Review for Consumables / Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
Table 48: World 16-Year Perspective for Consumables / Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
Table 49: World High Throughput Screening (HTS) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)

CANADA

JAPAN

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)

CHINA

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)

EUROPE

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)

FRANCE

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)

SPAINRUSSIAREST OF EUROPE

ASIA-PACIFIC

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)

AUSTRALIA

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)

INDIA

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Agilent Technologies, Inc.
Aurora Biomed Inc.
Axxam SpA
BD Biosciences
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
BioTek Instruments Inc.
BMG LABTECH GmbH
Charles River Laboratories International Inc.
Corning Inc.
Danaher Corporation
Evotec AG
F. Hoffmann-La Roche Ltd.
Genedata AG
IntelliCyt® Corporation
Luminex Corporation
Molecular Devices Inc.
Pall ForteBio LLC
PerkinElmer Inc.
Sigma-Aldrich Corp.
Tecan Group Ltd.
Thermo Fischer Scientific Inc.

Table Information

Report Attribute	Details
No. of Pages	273
Published	May 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 40.4 Billion
Forecasted Market Value ( USD ) by 2030	$ 45.3 Billion
Compound Annual Growth Rate	1.6%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5244EUR$5,450USD£4,437GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9963EUR$10,355USD£8,429GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15732EUR$16,350USD£13,310GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 41 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global High Throughput Screening Market by Product (Instrument, Consumable, Service), Technology (Cell-based Assays, Lab-on-a-Chip, Label-free), Application (Drug Discovery, Life Sciences Research), End User (Pharma, Biotech, CRO) - Forecast to 2028

High Throughput Screening (HTS) Global Market Report 2024

High-throughput Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

2024 Global Forecast for High Throughput Screening (Hts) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

Global High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Screening Size (12-well Format, 1536-well Format, 24-well Format), Technology, Application, End User - Forecast 2024-2030